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Penyakit Mulut dan Kuku (PMK) adalah salah satu penyakit penting yang 
menginfeksi hewan sapi, kambing, domba dan babi serta beberapa jenis hewan 
liar. Penyakit ini penting secara ekonomi karena selain mengakibatkan angka 
mortalitas yang tinggi pada hewan muda, penurunan produksi susu maupun bahan 
asal hewan lainnya serta dapat mengakibatkan pembatasan perdagangan 
internasional bagi negara yang terinfeksi PMK. Selain dampak langsung dari 
penurunan produksi peternkan dan pembatasan perdagangan internasional, wabah 
PMK juga memberikan dampak yang serius bagi aspek sosial ekonomi dan 
industri pariwisata. Sampai saat ini, penyakit ini menyebar luas di Amerika 
selatan, Asia dan Africa. Mengingat arti pentingnya penyakit ini dan dampaknya 
secara global, maka penting untuk menyusun langkah strategis pencegahan dan 
eradikasi penyakit ini. Tulisan ini akan membahas beberapa langkah  strategis 
penting yang dapat dimplementasikan dalam program eradikasi PMK khususnya 
melalui kegiatan-kegiatan yang berbasis teknologi molecular mulai dari penyiapan 
vaksin, tes diagnostic sampai kegiatan monitoring status penyakit. 
 




Foot and mouth disease (FMD) 
is a severe vesicular infection that 
mainly infected cloven-hoofed 
animals, several domesticated 
ruminants, swine and large number 
of wildlife animal (Alexandersen et 
al., 2003b; Jamal and Belsham, 
2013). FMD known for its abilities to 
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infect the healthy animal in minimal 
doses with a rapid replication and a 
high level of viral excretion 
(Alexandersen et al., 2003a). This 
unique characteristic has placed 
FMD as one of the important 
infectious disease in the world.  
FMD endemic in many 
countries of Asia, Africa, South 
America and Europe and has shown 
an impressive ability to pass 
international boundaries. Though, it 
once eradicated from Europe during 
the 1960—1980, the severe epidemic 
in the UK in 2001 has showed that 
this disease can be re-introduced into 
free countries that have been free for 
more than a decade (Brehm et al., 
2008). During it epidemic in UK, 
FMD has caused a huge economic 
loses at around £2.75 billion. 
Furthermore, other indirect effects in 
the agricultural and tourism sectors 
are still difficult to measures 
(Alexandersen et al., 2003b). 
FMD is characterised by the 
formation of vesicles and erosions in 
the cutaneous mucosae and hairless 
area of the skin such as mouth and 
the hoofs. In endemic countries, 
FMD causes the losses of young 
animal and the decline of adult 
animal productivities (Brehm et al., 
2008). Although, FMD cause a low 
rate of mortality, this infection is one 
of high cost disease that difficult to 
control and eradicated (Alexandersen 
et al., 2003b).  
Regarding those devastating 
effects of FMD, it is urgently need a 
tools and strategies that capable to 
early recognise the infection, prevent 
the outbreaks of the disease and 
eradicate the disease. The 
development of a molecular-based 
techniques and strategies for rapid 
identification and characterization of 
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FMD play the vital roles in control 
and eradication programs (Le et al., 
2012). Thereby, the mixture of 
molecular biology, epidemiology and 
microbiology in molecular 
epidemiology of infectious diseases 
are a powerful tool to improve and 
enhance FMD control strategies. Due 
to its reasons, this literature review 
will present several molecular 
approach applications and its role in 
FMD eradication program. 
 
DESCRIPTION OF THE DISEASE 
a. The virus 
FMD is caused by foot and 
mouth disease virus (FMDV), a 
small single-stranded and positive-
sense RNA virus (Abdul-Hamid et 
al., 2011). This virus is a non-
enveloped virus with an icosahedral 
structure which belongs to genus 
Aphthovirus and Picornaviridae 
family (Alexandersen et al., 2003b).  
The RNA consists of three parts, the 
5′ untranslated region (5′ UTR), a 
long coding region and the 3′ 
untranslated region (3′ UTR)(Jamal 
and Belsham, 2013). The viral RNA 
has been translated into a polyprotein 
during the replication in the 
cytoplasmic and causing the 
formation of 12 structural and non-
structural proteins (Alexandersen et 
al., 2003b). The RNA of the virus is 
surrounded by a protein capsid that 
consists of 60 copies of the 
capsomers (Jamal and Belsham, 
2013). Each of the capsomer is 
composed by four structural protein, 
VP1, VP2, VP3 and VP4 (Klein, 
2009). The VP1, VP2 and VP3 are 
located at the surface of the virus and 
associated with the antigenic factor 
of the virus while VP4 is located in 
the internal part of the virus (Jamal 
and Belsham, 2013). Among these 
four structural polypeptides, VP1 has 
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been recognised for its important role 
in virus attachment, protective 
immunity, and serotype specificity 
(Alexandersen et al., 2003b; Ma et 
al., 2011). The VP1 consists of two 
vital immunogenic sites which is the 
G-H loop (at amino acid positions 
141–160) and the C-terminus 
(residues 200–213). The G-H loop 
contains of an arginine-glycine-
aspartic acid (RGD) motif that 
important in viral attachment into the 
host cell via an integrin receptor 
(Jamal and Belsham, 2013). The 
attachment of a region in the G-H 
loop of the VP1 protein on the 
surface of the viral capsid to the 
surface of host cells is considered as 
the primary initiation of the virus 
infection (Alexandersen et al., 
2003b; Klein, 2009). Due to the vital 
role of VP1 in virus attachment, the 
nucleotide sequences of the VP1 
coding region have been used for 
recognising the characterisation of 
FMDV strains. The phylogenetic 
analyses based on VP1 sequencing  
have been used also to identify the 
epidemiological relationships among 
FMDV genetic lineages and in the 
tracing of the original strains and 
movement of outbreak cases (Jamal 
and Belsham, 2013). 
FMDV has a wide range of 
antigenic variable that can be 
grouped into seven serotypes such as 
Southern African Territories (SAT) 
1, SAT 2, SAT 3, O, A, C and Asia 1 
(Abdul-Hamid et al., 2011). The 
phylogenetic studies of the VP1 gene 
sequence of FMDV show that there 
are at least 10 genotypes of serotype 
A, 10 topotypes of serotype O such 
as Europe-South America (Euro-SA), 
Middle East-South Asia (ME-SA), 
Southeast Asia (SEA), Cathay 
(CHY), West Africa (WA), East 
Africa 1 (EA-1), East Africa 2 (EA-
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2), East Africa 3 (EA-3), Indonesia-1 
(ISA-1), and Indonesia-2 (ISA-2) 
and 6 genotypes of serotype Asia 1 
(Le et al., 2012). 
b. Hosts 
As a disease with a wide range 
of hosts, FMD can infect various 
different animals, such as cattle, 
swine, sheep, goats, buffaloes and 70 
wild ruminants (Alexandersen and 
Mowat, 2005). 
c. Transmissions 
Typically, FMDVs spread through 
direct contact with infected animals 
such as through aerosolised droplets, 
saliva or fomites and the movement 
of infected animals (Alexandersen 
and Mowat, 2005). Transmission 
through the contaminated food and 
other indirect transmission such us 
human movements, contaminated 
farming tools, transportation 
vehicles, winds or wild animals and 
birds are the other alternatives in 
FMDV transmission pathways 
(Alexandersen et al., 2003b; 
Alexandersen and Mowat, 2005). 
d. Epidemiology 
Jamal and Belsham (2013) 
report that approximately 100 
countries have been infected by this 
disease.  In general, it can be seen 
that the spreading of seven FMD 
serotypes are not uniformly. For 
instance, in Africa there are five 
FMD serotypes that have been 
spread around the continent, like O, 
A, SAT-1, SAT-2 and SAT-3, in 
Asia there are three FMD serotypes 
O, A and Asia-1 and in South 
America there are two serotypes 
which are O and A serotype 
(Rweyemamu et al., 2008; Jamal and 
Belsham, 2013). However, Abdul-
Hamid et al. (2011) reports that in 
Middle East there is invasions of 
SAT-1 and SAT-2 from Africa, 
periodically.  









Figure 1. Geographical distribution of FMDV serotypes (Jamal and Belsham, 
2013) 
 
The FMD geographical map 
has shown that serotype O and A 
have widest range of distribution and 
have been proved as the major causes 
of FMD outbreaks in Europe, 
America, Asia and Africa. While 
serotype C that was infected Ethiopia 
in 2005, nowadays no longer exist at 
outside of the laboratory 
environments (Abdul-Hamid et al., 




The incubation period of FMD 
is very variable and rely on the host 
species, transmission pathways, 
serotype and its dose and the 
condition of the farming environment 
(Alexandersen et al., 2003b). 
The pharyngeal area especially 
the epithelial cells on the dorsal soft 
palate, the roof of the pharynx and 
the tonsil are the primary site of 
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FMD primary infection. In these 
areas, the virus can be survived for 1 
until 3 days before the viraemia can 
be recognised. After 2-3 days of viral 
replication in the epithelium of the 
primary sites, the virus will invade 
the local lymph nodes before they 
enter the blood circulation and 
caused the viraemia.  Viraemia 
usually happens for 4–5 days and 
through this circulation, the virus 
travel around the body and invade 
the targeted cells.  
During the infections, all the 
body secretions and excretions 
become infectious and can produce 
significant doses of virus. 
Eventually, saliva, nasal droplet and 
fluid, lachrymal fluid and milk and 
expired breath serve as infectious 
substrates that can spreading the 
virus and infected other susceptible 
animals. This process usually 
happens before the infected animal 
shows the clinical symptoms  
(Alexandersen et al., 2003b). 
Thereby, the spreading of the virus 
during this period become the critical 
phase in FMD transmission.  
 
f. Clinical symptoms and lesions 
Typically, the prominent 
characteristics of FMD are an acute 
febrile response and the formation of 
vesicles in the mouth and feet areas. 
The behavioural symptoms like 
lameness, a tucked up stance and 
reluctance to stand or moving around 
and Inappetence can be the early 
signals of FMD infections 
(Alexandersen et al., 2003b). 
Alexandersen et al. (2003b) also 
reported that in 1-2 days before the 
presence of vesicular lesions, the 
general symptoms like fever and pain 
may be detected from the animals. 
Afterwards, the vesicles can be seen 
on the snout or muzzle, teats, 
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mammary gland, prepuce, vulva and 
other sites of the skin, especially in 
the area around the mouth and the 
feet. At the end, the lesions on the 
ruminal pillars can be found in the 
post-mortem examination. 
The FMD infection in Bovine 
is characterized by the increase of the 
body temperature until 40.8°C, 
hypersalivation, lameness, 
depression and the decreasing of 
milk production. The most severe 
lesions can be observed in the 
mucosa of the lips, dorsum of the 
tongue, and the dental plate. 
Myocardial necrosis mostly happens 
in young animal and cause a low 
number of mortality rate (Kitching, 
2002; Alexandersen et al., 2003a; 
Gulbahar et al., 2007). 
In sheep and goats, the clinical 
signs are less severe than in the 
bovine. Mild lesions such as the 
vesicle formations rarely observed in 
the mouth of sheep and goats. The 
signs commonly superficial and 
transient and heal rapidly 
(Alexandersen et al., 2003). 
However, lameness through aphthae 
and inflammation at the cloves are 
two clinical manifestation that also 
can be seen from the infection 
(Alexandersen and Mowat, 2005).  
In contrast with the mild 
symptoms in sheep and goats, swine 
usually shows more severe clinical 
signs which mostly affect the feet 
region like, formation of vesicles in 
the epidermis of the feet (coronary 
band, interdigital clefts, and bulbs) 
and the oral region. Moreover, 
clinical signs like acute lameness, 
reluctance to stand, a dog-sitting 
posture, depression, loss of appetite, 
hypersalivation and fever also can be 
observed in the early-middle phase 
of the disease  (Alexandersen et al., 
2003b). The hoof  separation and 
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secondary infection on disrupted 
aphthae (fluid-filled blisters) which 
causes purulent arthritis of the pedal 
joint also doubled the complication 
of FMD infection in swine (Kitching 
and Alexandersen, 2002).  
 
MOLECULAR APPROACH 
a. Diagnostic techniques 
Regarding the rapid spreading 
of FMDV and the damaging effects 
on the economic sector caused by this 
disease. The sensitive and specific 
laboratory diagnostic test has been 
urgently needed in order to early 
recognise the original serotype of 
FMDV. Since the diagnosed based on 
clinical signs like high temperature, 
excessive salivation, formation of 
vesicles on the oral mucosa, on the 
nose plus the inter-digital spaces and 
coronary bands on the feet can be 
confused with other diseases, it is 
important to diagnose the disease 
based on laboratory examinations. 
For a long period of time, the 
virus neutralization test (VNT) has 
considered as the “gold standard” 
FMDV identification (OIE, 2012). 
However, this test is slower, and 
requires restrictive biocontainment 
facilities.   
Recently, the reverse 
transcription-polymerase chain 
reaction (RT-PCR) assays have been 
developed as the diagnostic test of 
FMDV infection (Alexandersen et al., 
2003b). As a nucleic acid recognition 
test, RT-PCR able to amplify genome 
fragments of FMDV samples such as 
epithelium, milk, serum and 
oropharynx materials (Reid et al., 
2003). Compare with other test, such 
as antigen-detection which faster but 
have lower sensitivity, RT-PCR has 
been proven as a faster, reliable, and 
sensitive technique for the rapid and 
sensitive identification of FMDV (Le 




Tahun 2017  30 
 
et al., 2012). A different RT-PCR 
assays have been developed to early 
recognise RNA of FMDV in 
epithelium, cell culture isolates and 
other tissues using universal primers 
for all seven serotypes of FMDV 
(Jamal and Belsham, 2013). 
Several specific serotype 
primers have been formed to identify 
of all seven serotypes of FMDV by 
RT-PCR assay (Jamal and Belsham, 
2013). Generally, primers that have 
designed for these tests target various 
regions of the FMDV genome like the 
5′ UTR, the open reading frame and 
the 3′ UTR. Nonetheless, the 
evaluation for universal and serotype-
specific diagnosis of FMDV on a 
wide range of field samples that 
representing all the seven FMDV 
serotypes have reported that there are 
no single primer sets are capable to 
identify the disease or typing of the 
virus. Regarding these reasons, 
multiplex assays which are 
incorporating more than one set of 
primers have been developed in order 
to gain better sensitivity of the test 
(Giridharan et al., 2005; Bao et al., 
2008). However, this conventional 
RT-PCR still could only serotyping 
particular groups of serotypes or 
individual isolates (Jamal and 
Belsham, 2013).  
Currently, real time RT-PCR 
(rRT-PCR) assay have been 
developed as the high throughput test 
that capable to quantify the genetic 
material of FMD starting sample. 
Two types of rRT-PCR TaqMan 
assays that commonly use are one 
targeting the internal ribosomal entry 
site (IRES) within the 5′ UTR and the 
other that targeting the 3D (RNA 
polymerase) coding sequence (Reid et 
al., 2002). 
Although, rRT-PCR assays are 
commonly used as a routine test for 
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FMD identification and quantification 
in many developed countries, these 
tests are still cannot differentiate the 
variety serotypes of FMDV. 
Moreover, the assays also unable to 
recognise a small number of FMDV 
isolates. As a result, it can be 
concluded that there is no single test 
that has an ability to detect FMDV 
with highly sensitivity degree.  
 
b. Molecular epidemiology 
FMD molecular epidemiology 
is based on the genetic differences 
among the FMD virus. The 
differentiation and comparison of 
whole viral genome sequencing have 
been used as the basic principle to 
distinguish the FMD virus that 
closely related. The genomic 
comparison of FMDV is the main 
product of RT-PCR amplification and 
nucleotide sequencing. Dendrograms 
by Knowles and Samuel (2003) that 
have shown the genomic relationship 
between FMDV field strain and the 
vaccine products based on the 1D 
gene sequencing is an example of 
molecular epidemiology application. 
Furthermore, molecular epidemiology 
also helps to identify the transmission 
routes of the FMD outbreaks. To 
perform this study, OIE (2012) has 
been suggested 3 methods based on 
VP1 analysis, first, the extraction of 
RNA directly from epithelial 
suspensions or from a low cell culture 
passage, second, performing an RT-
PCR of the complete 1D gene and 
third, define the nucleotide sequence 
of the PCR product at the 3’ end of 
the gene (OIE, 2012). 
 
c. Vaccine selections and matching 
Nowadays, there are many 
FMD-free countries have used free-
vaccination strategic to declare their 
FMD-freedom status. Those countries 
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prefer to use the slaughter strategy, 
movement regulations and zoo-
sanitary measures as a FMD control 
strategies. Their just apply 
vaccination in certain situations such 
as in a outbreaks cases (Barnett and 
Carabin, 2002). However, a mass 
routine vaccination has still applied in 
several countries or zones that have 
been recognised as FMD-free and 
endemic countries.  
Recently, FMD vaccines are 
produced by growing FMD live virus 
in BHK-21 cells.  Afterwards, the 
growing infected cells are harvested, 
concentrated and inactivated with 
binary ethyleneimine, eliminated the 
cellular debris and mixed for use with 
a buffer and adjuvant or with oil 
either aluminium hydroxide and 
saponin (Clavijo et al., 2004; 
Kitching et al., 2007). The protection 
of these vaccines is mainly produced 
by antibodies against FMDV 
structural proteins (SPs). The high 
response of the antibodies are the 
indicator of  the high protection 
vaccines (Doel, 2003).  
Based on basic selection of 
FMD vaccine, Paton et al. (2005) 
state that there are two important 
factors that should be afforded by a 
good vaccine which are how strong it 
can induce a strong immunity 
response (potency) and how closely 
related its serotype to the field 
serotype (antigenic match).  
FMD vaccines can be classified 
in two types of potency which are 
‘standard’ and ‘higher’ potency 
vaccines. Standard potency vaccines 
are vaccines that contain of minimum 
potency required with sufficient 
antigen and appropriate adjuvant. 
This vaccine usually uses in routine 
vaccination programs. While, higher 
potency vaccines commonly use in 
naïve populations along FMD 
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outbreaks. This type of vaccine 
capable to induce a rapid onset of 
protection (OIE, 2012). 
The major problems of FMD 
vaccination are its antigenic match 
and the cross-protection problem. As 
it mentions before, FMD has seven 
antigenically distinct serotypes which 
each serotype has a different variation 
of intratypic variants. This antigenic 
variation of FMD brings a major 
problem in FMD control strategies, as 
an vaccination with one FMD 
serotype cannot protect the animals 
from different serotypes and even the 
vaccination may not fully protect the 
animals from other subtypes within 
the same serotype (Parida, 2009). 
Thereby, in some areas, it is 
suggested to vaccinated the animals 
with more than one FMD strain per 
serotype in order to ensure broad 
antigenic coverage against prevailing 
viruses (OIE, 2012). 
Regarding the antigenic 
diversity of FMDV, the selection of 
FMDV strain plays a crucial role in in 
vaccine production (Kitching, 2005). 
The choice of the most suitable 
FMDV strain for the vaccine products 
become the vital part in vaccine 
production. The matching strain 
between field strain and vaccine 
strain can be confirmed by 
epidemiology molecular studies, for 
instance by the collection from 
different stages of an outbreak, 
different geographical areas, or from 
different hosts. Moreover, the field 
evidence of a suspected lack of 
vaccine potency, also can be used as a 
consideration in FMDV strain 
selection. Several matching tests like 
ELISA and VNT also can be done to 
ensure the matching strain (OIE, 
2012).  
Another issue associate with the 
FMD vaccination is the fact that FMD 
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vaccines unstable outside the range of 
2–8°C (Kitching et al., 2007) also 
bring a challenge to FMD vaccination 
program in tropical areas. Eventually, 
the combination of these vaccination 
problems causes an ineffective 
vaccination program in mostly 
endemic areas which located at 
tropical regions. 
 
d. Molecular approach to 
differentiate between vaccinated and 
convalescent animals  
For many years, vaccination is 
widely used to control the incident of 
the disease. Vaccination has 
considered as the most effective 
protocol to tackle FMD cases. 
However, some cases show that the 
vaccination program can be an 
obstacle in the FMD eradication 
program since it become a difficult to 
differentiate vaccinated animals and 
infected animals (Ma et al., 2011). 
Moreover, several studies also 
indicate that the vaccinated animals 
that were exposed by the FMDV can 
serve as FMDV carrier animals and 
spread the virus to the environment 
(Sariya et al., 2011; Sharma et al., 
2012). 
In the FMD control program, it 
is important to recognise and 
differentiate the infected animals and 
the vaccinated animals because both 
groups have the neutralizing 
antibodies in their serum (Jamal and 
Belsham, 2013). Thereby, it is 
urgently need the diagnostic test that 
can distinguish between infected and 
vaccinated animals.   
Nowadays, the antibodies to 
non-structural protein (NSP) of 
FMDV has been used by the scientist 
to develop diagnostic tests that able to 
differentiate the infected and 
vaccinated animals (Sariya et al., 
2011; Sharma et al., 2012). This 
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principle are based on fact that along 
the FMD natural infection, the viral 
replications can produce both 
immunogenic proteins which are 
structural (SP) and non-structural 
(NSP) proteins (Jamal and Belsham, 
2013). On the contrary, vaccines just 
consist of purified preparations of 
inactivated 146S virions that 
exclusively able to induce antibodies 
to structural protein (SP) (Jamal and 
Belsham, 2013). Thereby, it can be 
possible to distinguish the infected 
and vaccinated animals based on the 
presence of antibodies to NSPs. 
Previously, the 
radioimmunoprecipitation and 
enzyme linked immunoelectrotransfer 
blot assays had been used as the 
detection of anti-NSP antibodies. 
However, those assays are not 
effective in outbreak cases which 
have a large number of serum 
samples, moreover both test could not 
be done as rapid examinations (Jamal 
and Belsham, 2013). Regarding these 
reasons, presently, the scientists are 
using Differentiation of Infected from 
Vaccinated Animals (DIVA) as the 
main test to distinguish the infected 
and vaccinated animals.  
Recently, an important effort 
has been constructed to develop tests 
that can differentiate infected and 
vaccinated animals based on the 
varieties of NSPs (3ABC, 3AB, 3A, 
3B, 2A, 2B and 2C) (Uttenthal et al., 
2010).  At this moment, tests based 
on the presence of antibodies for the 
polyprotein 3ABC have been 
considered as the most important tests 
to identify the FMD infection in 
vaccinated populations (Uttenthal et 
al., 2010). The OIE has standardised 
the test system that mixes the 3ABC 
indirect ELISA (Panaftosa) for 
screening and an immunoblot test for 
antibodies against the 3A, 3B, 2C, 3D 
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and 3ABC NSPs as the confirmatory 
tests (Jamal and Belsham, 2013). 
Currently, several researches has been 
conducted to develop multiplex 
ELISA using different NSPs and 
peptides in order to enhance the 
sensitivity and specificity of FMD 
DIVA tests (Dundon et al., 2010). 
In addition, Dundon et al. 
(2010) also assert that there are two 
alternative principles of DIVA tests 
beside the DIVA based on the NSPs 
antibody detection, namely, DIVA 
tests based on mucosal antibody 
detection and DIVA based on cell-
mediated immune responses. DIVA 
tests based on mucosal antibody 
detection is based on the presence of 
mucosal IgA antibody. A fact that the 
FMD vaccine has a minimum effect 
on mucosal IgA antibody while in 
cattle with persisting oropharyngeal 
FMDV infection, a salivary IgA 
antibody has reached the highest level 
of the antibody has been used as 
alternative DIVA test to identify 
carrier animals of FMDV (Parida et 
al., 2006a; Parida, 2009). This DIVA 
test also has been carried out to detect 
the different species of FMDV carrier 
animals. Moreover, the test also has 
the ability to recognise the low-level 
contamination of NSPs in vaccine 
productions (Parida et al., 2006a). 
Moreover, DIVA test based on cell-
mediated immune responses has been 
used as a diagnostic test of FMD and 
as test to measure the post-
vaccination protection (Dundon et al., 
2010). The test is based on the level 
of IFN-gamma that usually emerge 
after the vaccination. This test also 
can be used to confirm the infection 
in vaccinated populations (Parida et 
al., 2006b). Nonetheless, this test 
should be verified with other FMD 
vaccine serotypes due to its effects to 
initiate cell-mediated immune 
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responses along the vaccination 
period which can be misinterpreted 
with FMD infection in the vaccinated 
animals (Dundon et al., 2010).  
 
e. Roles of DIVA in FMD 
eradication program 
Generally, the main purpose of 
vaccination program is to prevent and 
diminish the clinical manifestations of 
the infectious diseases. The 
vaccination also has been used as 
control management in eradication 
program of certain diseases in some 
particular areas.  In the viral 
vaccination program, vaccination has 
an ability to trigger the immune 
system of the hosts. However, several 
studies prove that sometimes, the 
vaccination cannot serve a fully 
protection to the hosts and in some 
cases vaccinated animals can act as 
carriers of the disease that able to 
spread the virus into the environment 
(Dundon et al., 2010). Consequently, 
it is important to differentiate 
vaccinated animals among the 
infected animals in outbreaks 
incidents and eradication programs. 
In FMD eradication program, 
the detection of infected and 
vaccinated animals is the crucial point 
to control the disease. Moreover, to 
prove the freedom status of certain 
areas or countries from FMD 
infections, differentiating the FMD 
infected animals from the vaccinated 
populations plays a vital role (Muller 
et al., 2010). This is because almost 
50% of FMD infected animals can act 
as FMD carriers in environment 
(Jamal and Belsham, 2013). The fact 
that FMDV can stay for more than 28 
days post-infection in the oropharynx 
of infected animals are the major 
threaten in control and eradication 
programs. Furthermore, the ability of 
the virus to spread in a long period 
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along asymptomatic phase also 
increases the dangerous of this 
infection.  Thus, the differential tools 
to determine the infected and 
vaccinated animals are urgently 
needed.  
Currently, DIVA has been used 
as the preferred tests to recognise the 
disease status of some regions. DIVA 
that combined with competition 
ELISA (C-ELISA) has designed to 
identify the antibodies of NSP 3ABC 
which is an indicator of FMD 
infection (Clavijo et al., 2004; Foord 
et al., 2007). 3ABC of FMD NSP has 
recognised as the most immunogenic 
proteins that can trigger the formation 
of long duration of antibody 
responses (Bruderer et al., 2004). 
NSP cloning and expression has 
brought new alternatives in FMD 
diagnostic approaches. As a result, 
FMD identification based on the 
detection of NSP antibodies is 
commonly accepted as a new 
diagnostic marker system. For 
example, DIVA has been used by 
South America government to 
monitor and evaluate the success of 
FMD eradication programs and to 
legitimise the status of “FMD-free 
with vaccination” in order to increase 
the export of livestock products 
(Dundon et al., 2010). In 1997, DIVA 
also had been used to promote FMD 
eradication program in pig 
populations in Taiwan (Chung et al., 
2003). 
 
INDONESIA AND POTENSIAL THREAT OF FMD 
There are three FMD serotypes 
that establish in south-east Asia, such 
as serotype O, A and Asia 1. These 
serotypes have infected seven 
countries such as, Cambodia, Laos, 
Malaysia, Myanmar, the Philippines, 
Thailand and Vietnam while other 
three countries are free from the 
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disease (Brunei, Indonesia and 
Singapore) (Gleeson, 2002; 
Rweyemamu et al., 2008). Although, 
Indonesia has sustained its freedom 
for more than two decades, it still 
important to protect the areas from 
external and internal threats.   
Regarding its position that near with 
FMD infected countries such as 
Malaysia and Thailand. It is crucial 
to protect the animal and human 
movement from those countries 
especially in the border areas.  To 
minimise the risk of FMD 
reinfection, the strict regulation and 
policy in animal trade and 
movement, biosecurity and regular 
surveillance should be taken by the 
government. Moreover, the 
continually campaign to raise public 
awareness due to the dangerous of 
infectious disease also should be 




FMD is a highly contagious 
disease that also causes the 
devastating effect to the economic 
sector. This disease can spread 
rapidly by a multitude of routes and 
infected a wide range of animal. 
Symptoms of the disease has been 
characterised by the formation of 
vesicles and erosions in the 
cutaneous mucosae and hairless area 
of the skin such as mouth and the 
hoofs. In order to prevent the 
outbreaks of the disease and to 
eradicate the disease, several 
molecular approaches should be 
developed and implemented as a part 
of infectious disease control 
program.   
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